Skip to content
★ Sign in to follow
BJ

Bruce J. Seeley

Executive
Directeur Exécutif et COO
CTI Biopharma CorpSeagen Inc.
Total declarations
11
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 11 Mar 2022 for CTI Biopharma CORP, €6,038.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Bruce J. Seeley: trading record in brief

Filings by Bruce J. Seeley span 2 companies, the busiest being CTI Biopharma Corp and Seagen Inc. Over a trading history stretching from 19 August 2011 to 31 December 2021, the count stands at 11 filings.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 11 March 2022: a share grant of €6,038, in CTI Biopharma Corp. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Bruce J. Seeley

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations11 total
  • ◆
    EVP, Chief Operating OfficerExecutivesCTI Biopharma Corp
    6,839 USD14SEC
    3,241 shares@ US$2.1129.4% of flowCommon StockSEC:0000899243-22-010769:1
  • ◆
    EVP, Chief Operating OfficerExecutivesCTI Biopharma Corp
    6,724 USD19SEC
    3,164 shares@ US$2.125100.0% of flowCommon StockSEC:0000899243-22-010769:0
  • ◆
    EVP, Chief Operating OfficerExecutivesCTI Biopharma Corp
    4,900 USD14SEC
    5,000 shares@ US$0.9830.1% of flowCommon StockSEC:0000899243-21-011366:0
  • ◆
    EVP, Chief Operating OfficerExecutivesCTI Biopharma Corp
    493 USD12SEC
    500 shares@ US$0.9867.2% of flowCommon StockSEC:0000891293-20-000046:0
  • ◆
    EVP, Chief Operating OfficerExecutivesCTI Biopharma Corp
    312 USD11SEC
    500 shares@ US$0.62363.7% of flowCommon StockSEC:0000891293-19-000002:0
  • ◆
    EVP, Chief Operating OfficerExecutivesCTI Biopharma Corp
    1,150 USD12SEC
    500 shares@ US$2.3013.5% of flowCommon StockSEC:0000891293-18-000072:0
  • ◆
    EVP, Chief Commercial OfficerExecutivesCTI Biopharma Corp
    1,523 USD12SEC
    5,000 shares@ US$0.304614.2% of flowCommon StockSEC:0000891293-17-000004:0
  • ◆
    EVP, Chief Commercial OfficerExecutivesCTI Biopharma Corp
    1,445 USD12SEC
    5,000 shares@ US$0.28912.9% of flowCommon StockSEC:0000891293-16-000170:0
  • ◆
    EVP, Chief Commercial OfficerExecutivesCTI Biopharma Corp
    0SEC
    300,000 shares0Common StockSEC:0000891293-15-000029:0
  • ◆
    EVP, CommericalExecutivesSeagen Inc.
    0SEC
    6,309 shares0Common StockSEC:0001203311-11-000089:0
  • ◆
    EVP, CommericalExecutivesSeagen Inc.
    0SEC
    10,000 shares0Common StockSEC:0001203311-11-000089:1

11 of 11 declarations